Sex-Dependent Efficacy of Dietary Fiber in Pediatric Functional Abdominal Pain

Sik Yu So,Shyam Badu,Qinglong Wu,Nazli Yalcinkaya,Yiming Mirabile,Robert Castaneda,Salma Musaad,Margaret Heitkemper,Tor C. Savidge,Robert J. Shulman
DOI: https://doi.org/10.1053/j.gastro.2023.12.011
IF: 29.4
2024-01-15
Gastroenterology
Abstract:Background & Aims Functional abdominal pain disorders (FAPDs) are more prevalent in female patients. Dietary fiber may alleviate FAPD symptoms; however, whether this effect is sex dependent remains unclear. We investigated the sex dependency of dietary fiber benefit on abdominal pain in children with FAPDs and explored the potential involvement of the gut microbiome. Methods In 2 cross-sectional cohorts of children with FAPDs (n = 209) and healthy control individuals (n = 105), we correlated dietary fiber intake with abdominal pain symptoms after stratifying by sex. We also performed sex-stratified and sex-interaction analyses on data from a double-blind trial in children with irritable bowel syndrome randomized to psyllium fiber (n = 39) or placebo (n = 49) for 6 weeks. Shotgun metagenomics was used to investigate gut microbiome community changes potentially linking dietary fiber intake with abdominal pain. Results In the cross-sectional cohorts, fiber intake inversely correlated with pain symptoms in boys (pain episodes: r = –0.24, P = .005; pain days: r = –0.24, P = 0.004) but not in girls. Similarly, in the randomized trial, psyllium fiber reduced the number of pain episodes in boys ( P = .012) but not in girls. Generalized linear regression models confirmed that boys treated with psyllium fiber had greater reduction in pain episodes than girls ( P = .007 for fiber × sex × time interaction). Age, sexual development, irritable bowel syndrome subtype, stool form, and microbiome composition were not significant determinants in the dietary fiber effects on pain reduction. Conclusions Dietary fiber preferentially reduces abdominal pain frequency in boys, highlighting the importance of considering sex in future dietary intervention studies for FAPDs. ( ClincialTrials.gov , Number NCT00526903)
gastroenterology & hepatology
What problem does this paper attempt to address?